The prevalence of chronic kidney disease among type 2 diabetes mellitus patients in central South Africa.

IF 1.2 Q2 MEDICINE, GENERAL & INTERNAL
William Mhundwa, Gina Joubert, Thabiso R Mofokeng
{"title":"The prevalence of chronic kidney disease among type 2 diabetes mellitus patients in central South Africa.","authors":"William Mhundwa,&nbsp;Gina Joubert,&nbsp;Thabiso R Mofokeng","doi":"10.4102/safp.v65i1.5663","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Type 2 diabetes mellitus (T2DM) is a leading cause of chronic kidney disease (CKD). The prevalence of CKD among T2DM patients in Africa is 22.0%. The cut-off age for dialysing diabetic patients in the resource-limited state sector in South Africa is 50 years. Type 2 diabetes mellitus patients who develop CKD are likely to be excluded from chronic dialysis and rely on control of risk factors, including blood pressure and blood glucose levels, to prevent CKD progression. We aimed to determine the prevalence of CKD among T2DM patients attending the diabetes clinic at Pelonomi Academic Hospital, Bloemfontein.</p><p><strong>Methods: </strong>In this retrospective cross-sectional study, medical records of patients (January 2016 and December 2018) were reviewed to collect demographic and clinical information.</p><p><strong>Results: </strong>In total, 244 records were reviewed. Sixty-one (25.0%, 95% confidence interval [CI]: 20% - 30.8%) T2DM patients had CKD. The rate of CKD was slightly higher in males (n = 24/81; 29.6%) compared with females (n = 37/163; 22.7%). Most patients with CKD (n = 58; 95.1%) were 50 years of age. Only 17.8% of patients achieved a glycosylated haemoglobin (HbA1c) of 7.0%. Blood pressure was controlled in 14.3% of hypertensive patients. Renin-angiotensin-aldosterone system inhibitors were used by 78.6% of patients.</p><p><strong>Conclusion: </strong>A high prevalence of clinically significant CKD among T2DM patients with poor prospects of chronic dialysis in a resource-limited setting was observed. The risk factors for CKD development and progression should be adequately managed in T2DM patients.Contribution: This study emphasises the need for further research and innovation to improve outcomes of T2DM patients with CKD in resource-constrained settings.</p>","PeriodicalId":22040,"journal":{"name":"South African Family Practice","volume":"65 1","pages":"e1-e6"},"PeriodicalIF":1.2000,"publicationDate":"2023-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244950/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"South African Family Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4102/safp.v65i1.5663","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Type 2 diabetes mellitus (T2DM) is a leading cause of chronic kidney disease (CKD). The prevalence of CKD among T2DM patients in Africa is 22.0%. The cut-off age for dialysing diabetic patients in the resource-limited state sector in South Africa is 50 years. Type 2 diabetes mellitus patients who develop CKD are likely to be excluded from chronic dialysis and rely on control of risk factors, including blood pressure and blood glucose levels, to prevent CKD progression. We aimed to determine the prevalence of CKD among T2DM patients attending the diabetes clinic at Pelonomi Academic Hospital, Bloemfontein.

Methods: In this retrospective cross-sectional study, medical records of patients (January 2016 and December 2018) were reviewed to collect demographic and clinical information.

Results: In total, 244 records were reviewed. Sixty-one (25.0%, 95% confidence interval [CI]: 20% - 30.8%) T2DM patients had CKD. The rate of CKD was slightly higher in males (n = 24/81; 29.6%) compared with females (n = 37/163; 22.7%). Most patients with CKD (n = 58; 95.1%) were 50 years of age. Only 17.8% of patients achieved a glycosylated haemoglobin (HbA1c) of 7.0%. Blood pressure was controlled in 14.3% of hypertensive patients. Renin-angiotensin-aldosterone system inhibitors were used by 78.6% of patients.

Conclusion: A high prevalence of clinically significant CKD among T2DM patients with poor prospects of chronic dialysis in a resource-limited setting was observed. The risk factors for CKD development and progression should be adequately managed in T2DM patients.Contribution: This study emphasises the need for further research and innovation to improve outcomes of T2DM patients with CKD in resource-constrained settings.

Abstract Image

南非中部2型糖尿病患者中慢性肾脏疾病的患病率
背景:2型糖尿病(T2DM)是慢性肾脏疾病(CKD)的主要原因。非洲T2DM患者中CKD患病率为22.0%。在南非资源有限的国有部门,透析糖尿病患者的截止年龄为50岁。发生CKD的2型糖尿病患者可能被排除在慢性透析之外,并依赖于控制危险因素,包括血压和血糖水平,来预防CKD的进展。我们的目的是确定在布隆方丹Pelonomi学术医院糖尿病诊所就诊的2型糖尿病患者中CKD的患病率。方法:通过回顾性横断面研究,回顾2016年1月至2018年12月患者的医疗记录,收集人口学和临床信息。结果:共审查病历244份。61例(25.0%,95%可信区间[CI]: 20% - 30.8%) T2DM患者合并CKD。男性CKD发病率略高(n = 24/81;29.6%)与女性相比(n = 37/163;22.7%)。大多数CKD患者(n = 58;95.1%)为50岁。只有17.8%的患者糖化血红蛋白(HbA1c)达到7.0%。14.3%的高血压患者血压得到控制。78.6%的患者使用肾素-血管紧张素-醛固酮系统抑制剂。结论:在资源有限的情况下,慢性透析前景不佳的T2DM患者中,临床显著的CKD患病率很高。T2DM患者CKD发生和进展的危险因素应得到充分的管理。贡献:本研究强调需要进一步研究和创新,以改善资源受限条件下T2DM合并CKD患者的预后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
South African Family Practice
South African Family Practice MEDICINE, GENERAL & INTERNAL-
CiteScore
1.50
自引率
20.00%
发文量
79
审稿时长
25 weeks
期刊介绍: South African Family Practice (SAFP) is a peer-reviewed scientific journal, which strives to provide primary care physicians and researchers with a broad range of scholarly work in the disciplines of Family Medicine, Primary Health Care, Rural Medicine, District Health and other related fields. SAFP publishes original research, clinical reviews, and pertinent commentary that advance the knowledge base of these disciplines. The content of SAFP is designed to reflect and support further development of the broad basis of these disciplines through original research and critical review of evidence in important clinical areas; as well as to provide practitioners with continuing professional development material.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信